DUALITYBIO-B (09606) plans to issue RMB shares and list on the Shanghai Stock Exchange's Sci-Tech Innovation Board.

DUALITYBIO-B (09606) announced on October 17, 2025, that the company's board of directors has decided to issue ordinary shares to be listed on the Shanghai Stock Exchange Sci-Tech Board and traded in Renminbi. The proposed issuance of Renminbi shares is subject to and limited by market conditions, further approval from the board of directors, approval from shareholders at the company's shareholder meeting, and necessary regulatory approvals. As of the date of this announcement, apart from the preliminary proposal to issue Renminbi shares and other information disclosed in this announcement, the board of directors has no other plans regarding the proposed issuance of Renminbi shares, nor have they made any applications to relevant regulatory authorities regarding the proposed issuance of Renminbi shares.